PURCHASE SECURES SUFFICIENT PRODUCT QUANTITIES FOR Q4 MARKET LAUNCH

TORONTO, Aug. 14, 2018 /CNW/ - Pure Global Cannabis Inc. (TSX.V: PURE) (OTC: PRCNF) (the "Company" or "Pure Global" or "PURE"), a vertically-integrated, growth-oriented life sciences cannabis company, is pleased to announce that its wholly-owned subsidiary, PureSinse Inc. ("PureSinse"), has agreed to purchase from The Supreme Cannabis Company, Inc. ("Supreme") (TSXV: FIRE) an additional 210kg of medical cannabis for resale.

PURE's President & CEO Malay Panchal stated: "We are very pleased to secure a significant volume of additional product that meets our standards of quality from our great partner, Supreme. With this order, our company will have ample cannabis inventory to go to market within the next few months, in addition to enabling us to launch several clinical studies in specific therapeutic areas."

PureSinse is one of the first Licensed Producers to receive a cultivation license prior to building out growing systems. Instead, the company focused its initial efforts and resources on R&D, and establishing sales, IT, and operational systems. This uniquely positions the company to generate sales more quickly and with less upfront capital outlay than its peers.

PURE is positioning itself to be a dominant player in the cannabis pharma, health & wellness, and consumer goods sectors by committing itself to creating unique cannabinoid-based delivery systems and formulations with sustainable packaging. The company will soon begin selling dried flower and cannabis oils, followed by capsules, sublingual sprays, edibles, vape pens, and ultimately a full range of premium quality CBD and cannabis-based consumer goods for medical and adult-legal sales. The company is also on track to obtain EU Good Manufacturing Practice (GMP) and ISO certifications in early 2019 for expanding its sales to international markets.

About Pure Global Cannabis

Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF) is a vertically-integrated, growth-oriented life sciences cannabis company led by experienced pharma-industry, horticultural, consumer packaged goods (CPG), and supply chain experts. The Company's wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR) focused on producing cannabis products for medical, wellness, health & beauty, and nutraceutical future legal adult use markets.

About Supreme Cannabis

The Supreme Cannabis Company Inc. (TSXV: FIRE) is a Canadian publicly traded company committed to providing premium brands and products that proudly reflect its consumers, people and uniquely innovative culture. The Company's portfolio includes its wholly-owned subsidiary and flagship brand 7ACRES.

7ACRES is a federally licensed producer of medical cannabis operating inside a 342,000-square-foot facility in Kincardine, Ontario. 7ACRES is dedicated to providing consumers with a premium-quality product that recognizes its customers are informed, discerning and value a brand and culture that aligns with their principles. 7ACRES brand success has been reflected in provincial supply agreements, where 7ACRES' product is consistently listed in the highest brand category available to recreational consumers.

To register to Pure Global's mailing list, please visit www.pureglobal.com. Follow @pureglobalcanna on Twitter and Facebook and @pureglobalcannabis on Instagram.

FORWARD-LOOKING STATEMENTS

This news release contains certain forward-looking statements, including, but not limited to, statements about Pure Global's future plans and intentions. Wherever possible, words such as "may", "will", "should", "could", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict" or "potential" or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management's current beliefs and are based on information currently available to management as at the date hereof.

Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Pure Global Cannabis Inc.

For further information: regarding Pure Global, please contact: Stephen Pynn, VP Corporate Development, Telephone: 1-866-899-PURE (7873), E-mail: [email protected]; Malay (Mel) Panchal, President & CEO, Telephone: 1-866-899-PURE (7873), E-mail: [email protected]